These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9048227)
1. Method for determining whether the number of hepatocytes in rat liver is increased after treatment with the peroxisome proliferator gemfibrozil. Carthew P; Maronpot RR; Foley JF; Edwards RE; Nolan BM J Appl Toxicol; 1997; 17(1):47-51. PubMed ID: 9048227 [TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F344 rats. Sausen PJ; Teets VJ; Voss KS; Miller RT; Cattley RC Cancer Lett; 1995 Nov; 97(2):263-8. PubMed ID: 7497472 [TBL] [Abstract][Full Text] [Related]
3. The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Carthew P; Edwards RE; Nolan BM Toxicol Sci; 1998 Jul; 44(1):46-51. PubMed ID: 9720140 [TBL] [Abstract][Full Text] [Related]
4. New approaches to the quantitation of hypertrophy and hyperplasia in hepatomegaly. Carthew P; Edwards RE; Nolan BM Toxicol Lett; 1998 Dec; 102-103():411-5. PubMed ID: 10022288 [TBL] [Abstract][Full Text] [Related]
5. The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in wistar and fisher rats. Macan M; Konjevoda P; Lovric J; Koprivanac M; Kelava M; Vrkic N; Bradamante V Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):428-35. PubMed ID: 21223511 [TBL] [Abstract][Full Text] [Related]
6. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat. Amacher DE; Beck R; Schomaker SJ; Kenny CV Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of gemfibrozil and clofibric acid on peroxisomal enzymes and cholesterol synthesis of rat hepatocytes. Hashimoto F; Taira S; Hayashi H Biol Pharm Bull; 1998 Nov; 21(11):1142-7. PubMed ID: 9853402 [TBL] [Abstract][Full Text] [Related]
8. Hepatic peroxisome proliferation in rodents and its significance for humans. Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416 [TBL] [Abstract][Full Text] [Related]
9. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species. Gray RH; de la Iglesia FA Hepatology; 1984; 4(3):520-30. PubMed ID: 6586630 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorgenicity. Hofstra AH; King LM; Walker RM Fundam Appl Toxicol; 1995 Sep; 27(2):277-86. PubMed ID: 8529824 [TBL] [Abstract][Full Text] [Related]
11. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation. Rao MS; Subbarao V Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. Corton JC; Bocos C; Moreno ES; Merritt A; Cattley RC; Gustafsson JA Biochimie; 1997; 79(2-3):151-62. PubMed ID: 9209713 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. Leung LK; Glauert HP Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126 [TBL] [Abstract][Full Text] [Related]
14. Conditions influencing the induction of peroxisomal beta-oxidation in cultured rat hepatocytes. Foxworthy PS; Eacho PI Toxicol Lett; 1986 Feb; 30(2):189-96. PubMed ID: 3458334 [TBL] [Abstract][Full Text] [Related]
15. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells. Perrone CE; Williams GM Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014 [TBL] [Abstract][Full Text] [Related]
16. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study. Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002 [TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. James NH; Roberts RA Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of gemfibrozil effects on a marine fish (Sparus aurata) combining gene expression with conventional endocrine and biochemical endpoints. Teles M; Fierro-Castro C; Na-Phatthalung P; Tvarijonaviciute A; Soares AMVM; Tort L; Oliveira M J Hazard Mater; 2016 Nov; 318():600-607. PubMed ID: 27474849 [TBL] [Abstract][Full Text] [Related]
19. Effects of benfluorex and fenofibrate treatment on mitochondrial and peroxisomal marker enzymes in rat liver. Van Veldhoven P; Declercq PE; Debeer LJ; Mannaerts GP Biochem Pharmacol; 1984 Apr; 33(7):1153-5. PubMed ID: 6712725 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferation and hepatotoxicity in rodents. Grasso P Biochem Soc Trans; 1985 Oct; 13(5):861-2. PubMed ID: 4065422 [No Abstract] [Full Text] [Related] [Next] [New Search]